Showing results (51-60 of 220) with videos related to
Sort By:
Pageof 22
Nature Clinical Practice. Nephrology|August 26, 2006
Guidelines for disorders of mineral metabolism and secondary hyperparathyroidism should not yet be modifiedJoachim H Ix, L Darryl Quarles, Glenn M ChertowEndocrinology|June 13, 2009
Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulatorValentin David, Aline Martin, Anne-Marie Hedge, et al.American Journal of Physiology. Endocrinology and Metabolism|December 9, 2004
Targeted overexpression of G protein-coupled receptor kinase-2 in osteoblasts promotes bone lossLiming Wang, Shiguang Liu, L Darryl Quarles, et al.Frontiers in Endocrinology|June 28, 2018
Role of Fibroblast Growth Factor-23 in Innate Immune ResponsesElizabeth A Fitzpatrick, Xiaobin Han, Zhousheng Xiao, et al.Kidney International|September 25, 2008
Parathyroid-specific interaction of the calcium-sensing receptor and G alpha qMin Pi, Ling Chen, MinZhao Huang, et al.Trends in Pharmacological Sciences|October 1, 2023
Structural asymmetry in FGF23 signalingShih-Hsien Liu, Zhousheng Xiao, Jeremy C Smith, et al.Journal of the American Society of Nephrology : JASN|August 30, 2008
FGFR3 and FGFR4 do not mediate renal effects of FGF23Shiguang Liu, Luke Vierthaler, Wen Tang, et al.American Journal of Physiology. Endocrinology and Metabolism|September 13, 2007
Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp miceShiguang Liu, Wen Tang, Jianping Zhou, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 12, 2003
Serum FGF23 levels in normal and disordered phosphorus homeostasisThomas J Weber, Shiguang Liu, Olafur S Indridason, et al.Drug Discovery Today|January 21, 2024
Drugging the entire human proteome: Are we there yet?Micholas Dean Smith, L Darryl Quarles, Omar Demerdash, et al.Pageof 22